TL;DR
This paper outlines the INTERBIO-21st Newborn Case-Control Study, a large-scale international effort to deeply phenotype preterm birth and small for gestational age (SGA) syndromes. By integrating clinical, biological, and environmental data, the study aims to move beyond broad classifications to a more functional understanding of these complex conditions, paving the way for improved diagnostics and interventions.
What Problem Does This Paper Address?
Preterm birth and small for gestational age (SGA) are major contributors to infant mortality and long-term health issues. However, current classifications of these conditions are often broad and non-specific, hindering our ability to understand their underlying mechanisms and develop targeted interventions. The INTERGROWTH-21st project previously established international growth standards, but Phase II, the INTERBIO-21st study, aims to delve deeper. It tackles the challenge of understanding the complex interplay of environmental exposures, clinical conditions, and nutritional factors that contribute to these syndromes, moving towards a more mechanistic and functional classification.
Methods
The INTERBIO-21st Newborn Case-Control Study employs a "deep phenotyping" approach. This involves collecting a comprehensive array of data, including:
- Longitudinal Clinical Data: Detailed information on pregnancy, delivery, and infant health.
- Growth Data: Standardized measurements of weight, length, and head circumference.
- Biological Samples: Maternal blood, umbilical cord blood, placental tissue, maternal feces, and infant buccal swabs are collected for future nutritional, biochemical, omic, and histological analyses.
- Neurodevelopmental Assessment: At 1 and 2 years of age, infants undergo assessments of cognition, language, motor skills, behavior, sleep patterns, and visual acuity using the INTERGROWTH-21st Neurodevelopment Package.
- Body Composition: In a subset of infants, body composition is assessed using air displacement plethysmography.
The study design utilizes a case-control approach, with specific definitions for preterm birth and SGA cases and controls, aiming for a 2:1 ratio of controls to cases. Rigorous standardization procedures, quality control measures, and a dedicated data management system are in place to ensure data integrity across multiple international sites.
Datasets
The study leverages data collected between 2012 and 2018 from seven sites across Brazil, Kenya, Pakistan, South Africa, Thailand, and the UK. This includes:
- Longitudinal clinical data from mothers and infants.
- Biological samples (maternal blood, cord blood, placenta, maternal feces, infant buccal swabs).
- Anthropometric measurements of newborns.
- Neurodevelopmental assessment data at 1 and 2 years of age.
- Newborn body composition data from two sites.
This extensive dataset builds upon the foundation of the INTERGROWTH-21st Project, which previously generated international standards for fetal and childhood growth.
Key Insights and Ideas
- Moving Beyond Broad Classifications: The core idea is that current broad definitions of preterm birth and SGA are insufficient. By collecting detailed, multi-faceted data, the study aims to identify distinct underlying mechanisms and functional classifications for these syndromes.
- The Power of "Deep Phenotyping": The study emphasizes integrating diverse data types (clinical, biological, environmental) to gain a holistic understanding of complex health conditions, rather than relying on single markers.
- Environmental Influences are Key: A central hypothesis is that environmental exposures (nutrition, infections, pregnancy complications) play a crucial role in shaping fetal growth and neurodevelopment, and the study is designed to explore these interactions.
- Epigenetics as a Potential Mediator: The paper highlights the growing evidence that epigenetic patterns, particularly in the placenta, can reflect intrauterine exposures and may mediate the link between environmental factors and adverse outcomes.
- A Unique Resource for Future Research: The comprehensive dataset and biorepository assembled by this study are expected to be invaluable for future research into the complex etiologies of preterm birth and SGA.
Key Results
As this paper describes the study protocol, no results are presented. However, the study is designed to generate insights into:
- The mechanisms underlying preterm birth and SGA.
- The influence of environmental exposures, clinical conditions, and nutrition on growth and neurodevelopment.
- Potential functional classifications for these syndromes.
- The role of epigenetics in mediating adverse pregnancy outcomes.
Limitations and Future Work
- Definition of Preterm Birth: One reviewer raised a concern about the study's definition of preterm birth as delivery prior to 38 weeks, which differs from the commonly accepted definition of prior to 37 weeks. The authors' justification based on neonatal outcome was questioned, with the reviewer suggesting this could lead to overlap and make it harder to identify distinct mechanistic differences.
- Exclusion of Post-Term Pregnancies: The study did not include a cohort of post-term pregnancies, which a reviewer suggested could have provided valuable insights into labor onset mechanisms.
- Nutritional Analysis Details: The paper mentions "nutritional analysis" but lacks specific details on whether this includes metabolomic analysis, food diaries, or breast milk analysis, which are crucial for understanding growth and neurodevelopment.
- Ancillary Study Sample Sizes: The sample sizes for ancillary studies (body composition, postnatal follow-up) are not explicitly stated, nor is it clear if these studies are for all enrollees or a subset.
Future work will involve analyzing the collected data to address the study's objectives, aiming to enhance medical knowledge and provide new insights into environmental influences on human growth and neurodevelopment. The study's findings will be disseminated widely through various channels.
Summary updated